- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07203027
Using Brain Imaging to Understand and Treat Anxiety-Related Avoidance Behaviors
This groundbreaking research study at Emory University aims to transform our understanding of how anxiety disorders work and develop more effective treatments. For decades, scientists believed that fear was the primary driver of anxiety disorders, with treatments like exposure therapy focusing on reducing fear responses. However, recent discoveries have revealed that avoidance behavior – the tendency to steer clear of anxiety-provoking situations – may actually be a more important mechanism underlying anxiety disorders than previously thought.
The study uses innovative brain imaging technology combined with advanced computer modeling to examine how avoidance behaviors develop and persist in people with anxiety. Researchers will use functional magnetic resonance imaging (fMRI) to observe brain activity while participants complete specially designed tasks that measure avoidance behavior. What makes this research particularly innovative is the combination of brain scanning with real-world monitoring through smartphone apps that track participants' daily movements and avoidance patterns over several weeks.
For patients and caregivers living with anxiety, this research offers hope for more targeted and effective treatments. Many people with anxiety disorders find that despite their best efforts, they continue to avoid situations that trigger their anxiety – whether it's social gatherings, work responsibilities, or everyday activities. This avoidance often creates a cycle where anxiety worsens over time as opportunities for positive experiences diminish. Understanding the specific brain mechanisms behind avoidance could lead to treatments that directly target these patterns rather than just addressing fear responses.
The study will involve two main groups of participants. The first group of 120 adults will help researchers develop a 'brain signature' that identifies when someone is experiencing threat-related anxiety. The second group of 163 adults with clinically significant anxiety and avoidance behaviors will participate in multiple scanning sessions and complete several weeks of real-world monitoring. This comprehensive approach allows researchers to connect what happens in the brain during laboratory tasks with how avoidance manifests in daily life.
From a patient perspective, this research is particularly important because it recognizes that avoidance isn't just a symptom of anxiety – it may be a core mechanism that maintains and worsens anxiety over time. Many current treatments focus on helping people confront their fears, but this study could provide the scientific foundation for interventions that specifically target avoidance patterns. The researchers hypothesize that by understanding the brain basis of avoidance, they can develop more personalized and effective approaches to treatment.
The practical implications of this research are significant. If successful, the findings could lead to:
- More accurate diagnostic tools that identify specific avoidance patterns
- Personalized treatment plans based on individual brain activity patterns
- New therapeutic approaches that directly target avoidance mechanisms
- Better monitoring of treatment progress through both brain imaging and real-world tracking
- Earlier intervention for people developing problematic avoidance patterns
For caregivers, this research underscores the importance of recognizing avoidance behaviors as more than just 'coping strategies' but as potential maintenance factors in anxiety disorders. The study's use of ecological momentary assessment (through smartphone surveys) and passive sensing (through GPS tracking) represents a more holistic approach to understanding how anxiety affects daily functioning beyond what can be observed in clinical settings.
The broader field of anxiety research has been shifting toward understanding the complex interplay between different anxiety mechanisms, and this study represents a significant step forward in that direction. By combining advanced computational modeling with cutting-edge neuroimaging and real-world monitoring, the researchers aim to create a comprehensive picture of how avoidance behavior develops and persists in anxiety disorders. This multi-method approach could bridge the gap between laboratory findings and clinical applications, potentially leading to more effective interventions that address the root causes of anxiety-related disability.
This research is particularly timely given the increasing recognition of anxiety disorders as major contributors to global disability. The COVID-19 pandemic has further highlighted how avoidance behaviors can become entrenched and significantly impact quality of life. By developing a deeper understanding of the neural basis of avoidance, this study could contribute to more effective treatments that help people reclaim their lives from anxiety's constraints. The collaboration between Emory University and the National Institute of Mental Health ensures that the findings will reach both scientific and clinical audiences, accelerating the translation of research discoveries into practical treatments.
Upcoming Clinical Trials
-
NCT07814352RecruitingLeptomeningeal Disease (LMD)
-
NCT07814378Not yet recruitingAnemia | Pregnancy | Iron Deficiency Anaemia in Childbirth
-
NCT07814391Not yet recruitingPeri-Implantitis and Peri-implant Mucositis
-
NCT07814404Not yet recruiting
-
NCT07814417Not yet recruiting
-
NCT07814443Not yet recruiting
-
NCT07814456RecruitingInflammatory Bowel Disease | Ulcerative Colitis (UC)
-
NCT07814495Not yet recruiting
-
NCT07814508RecruitingDiabetes Mellitus | Diabetes Mellitus Type 2 | Sleep Quality | Ecological Momentary Assessment | Continuous Glucose Monitoring System | Diabetes (DM) | Diabetes Distress | Fear of Hypoglycemia | Diabetes Mellitus Type 1 | Glycemic Responses
-
NCT07814534Not yet recruitingParkinson Disease (PD)
-
NCT07814547RecruitingCarpal Tunnel Syndrome (CTS)